Detalhe da pesquisa
1.
Humanized Mice for the Study of Immuno-Oncology.
Trends Immunol
; 39(9): 748-763, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30077656
2.
Improvement of the anti-proliferative activity of the peptide ERα17p in MCF-7 breast cancer cells using nanodiamonds.
Ann Pharm Fr
; 77(6): 488-495, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31563266
3.
Activation of IFN/STAT1 signalling predicts response to chemotherapy in oestrogen receptor-negative breast cancer.
Br J Cancer
; 114(2): 177-87, 2016 Jan 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-26695443
4.
Phase II Trial of Bevacizumab in Combination With Temozolomide as First-Line Treatment in Patients With Metastatic Uveal Melanoma.
Oncologist
; 21(3): 281-2, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26911405
5.
HDAC inhibition does not induce estrogen receptor in human triple-negative breast cancer cell lines and patient-derived xenografts.
Breast Cancer Res Treat
; 149(1): 81-9, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25503779
6.
Human breast cancer and lymph node metastases express Gb3 and can be targeted by STxB-vectorized chemotherapeutic compounds.
BMC Cancer
; 14: 916, 2014 Dec 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-25476116
7.
Vasculature analysis of patient derived tumor xenografts using species-specific PCR assays: evidence of tumor endothelial cells and atypical VEGFA-VEGFR1/2 signalings.
BMC Cancer
; 14: 178, 2014 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-24625025
8.
Targeting calcineurin activation as a therapeutic strategy for T-cell acute lymphoblastic leukemia.
Nat Med
; 13(6): 736-41, 2007 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-17515895
9.
Optimization of tumor xenograft dissociation for the profiling of cell surface markers and nutrient transporters.
Lab Invest
; 93(5): 611-21, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23459372
10.
A multicentre, phase II trial of ofatumumab monotherapy in relapsed/progressive diffuse large B-cell lymphoma.
Br J Haematol
; 163(3): 334-42, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24032456
11.
Autologous stem cell transplantation as a first-line treatment strategy for chronic lymphocytic leukemia: a multicenter, randomized, controlled trial from the SFGM-TC and GFLLC.
Blood
; 117(23): 6109-19, 2011 Jun 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-21406717
12.
Polymeric encapsulation of a ruthenium(ii) polypyridyl complex: from synthesis to in vivo studies against high-grade epithelial ovarian cancer.
Chem Sci
; 14(2): 362-371, 2023 Jan 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36687351
13.
Patient-derived zebrafish xenografts of uveal melanoma reveal ferroptosis as a drug target.
Cell Death Discov
; 9(1): 183, 2023 Jun 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37321991
14.
FAK Inhibitor-Based Combinations with MEK or PKC Inhibitors Trigger Synergistic Antitumor Effects in Uveal Melanoma.
Cancers (Basel)
; 15(8)2023 Apr 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37190207
15.
Identification of a human estrogen receptor α tetrapeptidic fragment with dual antiproliferative and anti-nociceptive action.
Sci Rep
; 13(1): 1326, 2023 01 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36693877
16.
High-content drug screening in zebrafish xenografts reveals high efficacy of dual MCL-1/BCL-XL inhibition against Ewing sarcoma.
Cancer Lett
; 554: 216028, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36462556
17.
The mutational landscape of skull base and spinal chordomas and the identification of potential prognostic and theranostic biomarkers.
J Neurosurg
; 139(5): 1270-1280, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37029667
18.
Patient Derived Xenografts (PDX) Models as an Avatar to Assess Personalized Therapy Options in Uveal Melanoma: A Feasibility Study.
Curr Oncol
; 30(10): 9090-9103, 2023 10 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37887557
19.
Netrin-1 blockade inhibits tumor associated Myeloid-derived suppressor cells, cancer stemness and alleviates resistance to chemotherapy and immune checkpoint inhibitor.
Cell Death Differ
; 30(10): 2201-2212, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37633969
20.
Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models.
Clin Cancer Res
; 29(7): 1317-1331, 2023 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36602782